In quest to meet user fee goals, FDA’s per­for­mance con­tin­ues down­ward trend

A re­cent up­date to the FDA’s run­ning tal­ly of how it’s meet­ing its user fee-re­lat­ed per­for­mance goals dur­ing the pan­dem­ic shows an agency that is not out of the woods yet.

The lat­est num­bers re­veal that for a sec­ond straight quar­ter in 2021, the FDA has met its user fee goal dates for 93% of orig­i­nal new drug ap­pli­ca­tions, which com­pares with 94% and 98% for the pre­vi­ous two quar­ters in 2020, re­spec­tive­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.